21st Annual Duke Debates: Controversies in the Management of Hematologic Malignancies

August 14, 2020

This annual event brings together experts in the field of Hematologic Malignancies to debate and discuss advances in treatment for these cancers, novel treatment options, and debate current treatment paradigms. There is a mini session focusing on the management of immunotherapy and its use in solid tumors as well as the acute and late toxicities of CAR-T.

Learning Objectives

  • Describe emerging data and recent advances in the management of both malignant and benign hematologic disease.
  • Examine the use of immunotherapy in the management of solid tumors.
  • Compare traditional and emerging treatment options in the management of hematologic disease.
  • Examine the management of acute and late toxicities of CAR-T and immune therapies.
  • Examine the decision making strategies considered in choosing the optimal induction regimen and approaches to consolidation therapy post-transplant for patients with multiple myeloma.
Course summary
Available credit: 
  • 6.25 ABIM MOC
  • 6.25 ACPE - Pharmacist
  • 6.25 AMA PRA Category 1 Credit(s)™
  • 6.25 ANCC
  • 6.25 Attendance
Registration Opens: 
08/14/2020
Registration Expires: 
08/13/2021
Activity Starts: 
08/14/2020 - 8:05am EDT
Activity Ends: 
08/14/2020 - 4:45pm EDT
Add to calendar: 
Rating: 
0
Durham, NC 27708
United States

Available Credit

  • 6.25 ABIM MOC
  • 6.25 ACPE - Pharmacist
  • 6.25 AMA PRA Category 1 Credit(s)™
  • 6.25 ANCC
  • 6.25 Attendance
Please login or register to take this course.